Sign inJoin free

Watch / Small Cap

Ron gains conviction | Dermot's picks for rising rates | Like microcaps? Introducting Acorn Capital

8 Sept 202333:04

Ron gains conviction | Dermot's picks for rising rates | Like microcaps? Introducting Acorn Capital

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Ron Shamgar of Tamim Asset Management discussed standout performers from the recent reporting season. Symbio Holdings (SYM), a telco software provider, showed promising growth potential with strong second-half performance and a takeover offer from Superloop. EML Payments (EML) impressed with cost reduction efforts and growth in its gift and incentive division. Helloworld (HLO), a travel agency, delivered strong results, benefiting from increased travel demand and a resilient customer demographic. Ron sees undervalued opportunities in these companies, particularly Helloworld.

Dermot Ryan of Renaissance Asset Management discussed the lithium market's recent developments and the dynamics within the resource sector. He noted a shift in focus from lithium developers to established producers like Orocobre (AKE), which is set to merge with Galaxy and then Livent. Ryan emphasised that strategic players, particularly American companies like Albemarle (NYSE: ALB), are entering the lithium market, seeking large-scale assets. He also touched on gold exploration, highlighting that investing in proven resources is safer than explorers due to the risk of capital raisings. Ryan is cautious about investing in consumer discretionary stocks due to rising interest rates and prefers insurers and insurance brokers, which have demonstrated pricing power and margin management. Ryan also noted the importance of pricing power for small-cap stocks, especially in an environment with high inflation.

Acorn Capital Investment Fund (ACQ), discussed by portfolio manager Robert Bruce, specialises in micro-cap stocks outside the top 250. They offer diversification across sectors, including healthcare and resources, with a unique focus on unlisted investments. Their dividend policy targets at least 5% of trailing NTA. Notably, they've found success in healthcare with investments like Clarity Pharmaceuticals and are optimistic about IT companies pivoting towards profitable growth. As market conditions stabilise, Acorn Capital sees opportunities for stock pickers in the micro-cap space.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy